Global Non-Alcoholic Steatohepatitis Biomarkers Market By Biomarker Type (Inflammation Biomarkers, Apoptosis Biomarkers, Fat Accumulation Biomarkers, Serum Biomarkers, Others (Fat metabolism, antioxidants, etc.)); By Diagnosis (Liver Biopsy, Histological assessment of liver tissue); By Patient Type (Adult, Pediatric); By End-User (Hospitals and Clinics, Research and Academic Institutes, Diagnostics, Pharma Companies, Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Report ID :AMI-967 | Category : Healthcare | Published Date : December, 2021 | Pages : 402 | Format :PDF

Request Sample